Overslaan en naar de inhoud gaan

 Alle verbonden artikelen

Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma.

Auteurs : Bobin A, Kyheng M, Guidez S, Gruchet-Merouze C, Richez V, Duhamel A, Karlin L, Kolb B, Tiab M, Araujo C, Meuleman N, Malfuson JV, Bourquard P, Lenain P, Perrot A, Roussel M, Jaccard A, Petillon MO, Belhadj-Merzoug K, Chretien ML, Fontan J, Rodon P, Schmitt A, Offner F, Voillat L, Cereja S, Kuhnowski F, Rigaudeau S, Decaux O, Humbrecht-Kraut C, Frayfer J, Fitoussi O, Roos-Weil D, Eisenmann JC, Dorvaux V, Voog EG, Moreau P, Avet-Loiseau H, Hulin C, Facon T, Leleu X
Jaar : 2022
Journal : Leukemia
Volume : 36
Pagina's : 881-884

Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma.

Auteurs : Leupin N, Zinzani PL, Morschhauser F, Dalle S, Maerevoet M, Michot JM, Ribrag V, Offner F, Beylot-Barry M, Moins-Teisserenc H, Zwaenepoel K, de Winne K, Battistella M, Hultberg A, Gandini D, Moshir M, Jacobs J, Delahaye T, Khan A, Zabrocki P, Silence K, Van Rompaey L, Borg C, Motta G, Melle F, Calleri A, Pauwels P, de Haard H, Pileri S, Bagot M
Jaar : 2022
Journal : Cancer
Volume : 128
Pagina's : 1004-1014

Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer.

Auteurs : Loi S, Salgado R, Adams S, Pruneri G, Francis PA, Lacroix-Triki M, Joensuu H, Dieci MV, Badve S, Demaria S, Gray R, Munzone E, Drubay D, Lemonnier J, Sotiriou C, Kellokumpu-Lehtinen PL, Vingiani A, Gray K, André F, Denkert C, Piccart M, Roblin E, Michiels S
Jaar : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pagina's : 3

Polypoid colon mucosa in a leukemia patient.

Auteurs : Lifrange F, Van Gossum A, Verset L, Bron D, Gomez-Galdon M, Demetter P
Jaar : 2022
Journal : Acta Gastroenterol Belg
Volume : 85
Pagina's : 118-119

Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective Analysis.

Auteurs : Massaro F, Meuleman N, Bron D, Vercruyssen M, Maerevoet M
Jaar : 2022
Journal : Cancers (Basel)
Volume : 14

The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study.

Auteurs : Zijlstra JM, Follows G, Casasnovas RO, Vermaat JSP, Kalakonda N, Choquet S, Hill B, Thieblemont C, Cavallo F, Cruz F, Kuruvilla J, Hamad N, Jaeger U, Caimi P, Gurion R, Warzocha K, Bakhshi S, Sancho JM, Schuster M, Egyed M, Offner F, Vassilakopoulos TP, Samal P, Ku M, Xu J, Corona K, Chamoun K, Shah J, Canales M, Maerevoet M
Jaar : 2022
Journal : Cancers (Basel)
Volume : 14

New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy.

Auteurs : Andreozzi F, Massaro F, Wittnebel S, Spilleboudt C, Lewalle P, Salaroli A
Jaar : 2022
Journal : Int J Mol Sci
Volume : 23

A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol.

Auteurs : Michiels S, Tricas-Sauras S, Dauvrin M, Bron D, Kirakoya-Samadoulougou F
Jaar : 2021
Journal : PLoS One
Volume : 16
Pagina's : e0253526

Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry.

Auteurs : Hernández-Boluda JC, Pereira A, Kröger N, Cornelissen JJ, Finke J, Beelen D, de Witte M, Wilson K, Platzbecker U, Sengeloev H, Blaise D, Einsele H, Sockel K, Krüger W, Lenhoff S, Salaroli A, Martin H, García-Gutiérrez V, Pavone V, Alvarez-Larrán A, Raya JM, Zinger N, Gras L, Hayden P, Czerw T, P McLornan D, Yakoub-Agha I
Jaar : 2021
Journal : Am J Hematol
Volume : 96
Pagina's : 1186-1194

Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma.

Auteurs : Manson G, Brice P, Herbaux C, Silva MG, Bouabdallah K, Deau B, Bouteloup J, Schiano JM, Nicolas-Virelizier E, Maerevoet M, Ghesquieres H, Stamatoullas A, Antier C, Carlo-Stella C, de Charette M, Poizeau F, Dercle L, Houot R
Jaar : 2021
Journal : Eur J Nucl Med Mol Imaging
Volume : 48
Pagina's : 1144-1153

Apoptotic and Non-Apoptotic Modalities of Thymoquinone-Induced Lymphoma Cell Death: Highlight of the Role of Cytosolic Calcium and Necroptosis.

Auteurs : Berehab M, Rouas R, Akl H, Duvillier H, Journe F, Fayyad-Kazan H, Ghanem G, Bron D, Lewalle P, Merimi M
Jaar : 2021
Journal : Cancers (Basel)
Volume : 13

Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study.

Auteurs : Maerevoet M, Zijlstra JM, Follows G, Casasnovas RO, Vermaat JSP, Kalakonda N, Goy A, Choquet S, Van Den Neste E, Hill B, Thieblemont C, Cavallo F, De la Cruz F, Kuruvilla J, Hamad N, Jaeger U, Caimi P, Gurion R, Warzocha K, Bakhshi S, Sancho JM, Schuster M, Egyed M, Offner F, Vassilakopoulos TP, Samal P, Ku M, Ma X, Corona K, Chamoun K, Shah J, Shacham S, Kauffman MG, Canales M
Jaar : 2021
Journal : J Hematol Oncol
Volume : 14
Pagina's : 111

SARS-CoV-2 infection in hematological patients during allogenic stem cell transplantation: A double case report.

Auteurs : Van Uytvanck A, Wittnebel S, Meuleman N, Loizidou A, Salengros JC, Spilleboudt C
Jaar : 2021
Journal : Clin Case Rep
Volume : 9
Pagina's : e04439

Intestinal presentation of non-Hodgkin lymphoma: Case report.

Auteurs : Kansoun A, Chamma L, Sadek M, Maerevoet M, Ghorra C, Abboud AA, Alam H
Jaar : 2021
Journal : Int J Surg Case Rep
Volume : 86
Pagina's : 106346

Hepatosplenic T-cell lymphoma: treatment challenges.

Auteurs : Bron D, de Leval L, Michiels S, Wittnebel S
Jaar : 2021
Journal : Curr Opin Oncol
Volume : 33
Pagina's : 406-411

Unplanned hospitalizations in older patients with cancer: Occurrence and predictive factors.

Auteurs : Lodewijckx E, Kenis C, Flamaing J, Debruyne P, De Groof I, Focan C, Cornélis F, Verschaeve V, Bachmann C, Bron D, Luce S, Debugne G, Van den Bulck H, Goeminne JC, Schrijvers D, Geboers K, Petit B, Langenaeken C, Van Rijswijk R, Specenier P, Jerusalem G, Praet JP, Vandenborre K, Lobele JP, Milisen K, Wildiers H, Decoster L
Jaar : 2021
Journal : J Geriatr Oncol
Volume : 12
Pagina's : 368-374

Role of imaging for diagnosis and management of aortic valve papillary fibroelastoma and cardiac amyloid light chain amyloidosis: a case report.

Auteurs : Dimov I, Meuleman N, de Cannière D, Unger P
Jaar : 2021
Journal : Eur Heart J Case Rep
Volume : 5
Pagina's : ytab322

The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings.

Auteurs : Merimi M, El-Majzoub R, Lagneaux L, Moussa Agha D, Bouhtit F, Meuleman N, Fahmi H, Lewalle P, Fayyad-Kazan M, Najar M
Jaar : 2021
Journal : Front Cell Dev Biol
Volume : 9
Pagina's : 661532

Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study.

Auteurs : Tremblay G, Daniele P, Breeze J, Li L, Shah J, Shacham S, Kauffman M, Engelhardt M, Chari A, Nooka A, Vogl D, Gavriatopoulou M, Dimopoulos MA, Richardson P, Biran N, Siegel D, Vlummens P, Doyen C, Facon T, Mohty M, Meuleman N, Levy M, Costa L, Hoffman JE, Delforge M, Kaminetzky D, Weisel K, Raab M, Dingli D, Tuchman S, Laurent F, Vij R, Schiller G, Moreau P, Richter J, Schreder M, Podar K, Parker T, Cornell RF, Lionel K, Choquet S, Sundar J
Jaar : 2021
Journal : BMC Cancer
Volume : 21
Pagina's : 993

Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.

Auteurs : Casasnovas RO, Follows G, Zijlstra JM, Vermaat JSP, Kalakonda N, Choquet S, Neste EVD, Hill B, Thieblemont C, Cavallo F, la Cruz F, Kuruvilla J, Hamad N, Jaeger U, Caimi PF, Gurion R, Warzocha K, Bakhshi S, Sancho JM, Schuster M, Egyed M, Offner F, Vassilakopoulos TP, Samal P, Ku M, Ma X, Chamoun K, Shah J, Canales M, Maerevoet M, Shacham S, Kauffman MG, Goy A
Jaar : 2021
Journal : Clin Lymphoma Myeloma Leuk